NIH Funding Opportunities (Notices, PA, RFA)

Subscribe to NIH Funding Opportunities (Notices, PA, RFA) feed
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 1 hour 57 min ago

Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trial Optional)

Fri, 2019-12-20 02:36
Funding Opportunity RFA-CA-20-023 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI U54 Resource-Related Research Projects. The applicants should propose to expand upon original research question(s) from specific projects or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this FOA are meant to incentivize independent validation and accelerate the suitability of these emerging technologies for appropriate research communities. As a component of the NCI IMAT program, this FOA aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery.

Limited Competition 4DN Data Coordination and Integration Center (U01 Clinical Trial Not Allowed)

Fri, 2019-12-20 01:50
Funding Opportunity RFA-RM-20-008 from the NIH Guide for Grants and Contracts. This Limited Competition Funding Opportunity Announcement (FOA) invites an application from the currently funded NIH Common Fund-supported Four-Dimensional Nucleome (4DN) Data Coordination and Integration Center (DCIC) to support Phase 2 of the 4DN program. The 4DN DCIC will have two major areas of responsibility: (1) Data Standards, Storage, Analysis, and Dissemination; and, (2) Consortium Interactions and Outreach. The 4DN DCIC will collect, store, curate, and disseminate all 4DN-generated data, metadata, analysis and visualization tools, computational models, and navigable reference maps. The DCIC will also lead the development of data and metadata standards, implementation of processing pipelines and analysis and visualization tools, and facilitate the broader use of 4DN data by experts and non-experts through outreach activities.

Limited Competition: 4DN Organizational Hub (U01 Clinical Trial Not Allowed)

Fri, 2019-12-20 01:50
Funding Opportunity RFA-RM-20-007 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites an application from the currently funded NIH Common Fund-supported 4D Nucleome Network (4DN) Organizational Hub (4DN-OH) to support Phase 2 efforts of this program. The overall programmatic goal of the OH is to provide administrative infrastructure for the 4DN Network and facilitate and coordinate all common activities of the 4DN Network.

NIH Operates Under a Continuing Resolution

Thu, 2019-12-19 12:50
Notice NOT-OD-20-046 from the NIH Guide for Grants and Contracts

Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21 Clinical Trial Not Allowed)

Thu, 2019-12-19 05:02
Funding Opportunity PAR-20-078 from the NIH Guide for Grants and Contracts. The goal of this funding opportunity is to stimulate the use of existing human datasets for well-focused secondary analyses to investigate novel scientific ideas or new models, systems, tools, methods, or technologies that have the potential for significant impact on biomedical or biobehavioral research in areas relevant to the NHLBI mission. This FOA actively supports the use of existing database resources to conduct additional analyses secondary to a project's originally-intended primary purpose. Applications may be related to, but must be distinct from, the specific aims of the original data collection. It will not support the collection of new data.

Novel Therapeutics Directed to Intracellular HIV Targets (R21 Clinical Trial Not Allowed)

Thu, 2019-12-19 04:25
Funding Opportunity RFA-AI-19-072 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support the development of novel therapeutics which are directed to intracellular HIV targets. During the HIV life cycle multiple viral associated proteins are expressed in the infected cell. All are critical to support assembly, release and maturation of the virus. Considering each protein has a defined role in the life cycle, therapeutically targeting one or more may be an effective strategy to obtain potent antiviral activity.

Notice of correction to PA-18-817 "Administrative Supplements for Research on Dietary Supplements"

Thu, 2019-12-19 02:09
Notice NOT-OD-20-052 from the NIH Guide for Grants and Contracts

Notice of Change to PAR-19-064, "Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)"

Thu, 2019-12-19 01:58
Notice NOT-DA-20-028 from the NIH Guide for Grants and Contracts

Broad Agency Announcement (BAA): NHP MHC and KIR Allele Discovery and Typing Technology Development, BAA-NIAID-DAIT-75N93019R00020

Wed, 2019-12-18 12:57
Notice NOT-AI-20-022 from the NIH Guide for Grants and Contracts

Announcing the Interagency Collaborative Animal Research Education (ICARE) 2020 Workshop Schedule and Open Registration

Wed, 2019-12-18 12:33
Notice NOT-OD-20-045 from the NIH Guide for Grants and Contracts

Pages